Psychometric Properties of the Ulcerative Colitis Electronic Diary (UC e-Diary) in Adult Patients with Moderate-to-Severe Ulcerative Colitis

被引：0
|
作者：
Tahir, Muna J. [1 ]
Shahraz, Saeid [1 ,2 ]
Wang, Song [3 ]
Nagy, Peter [4 ]
Kamble, Pravin [3 ]
机构：
[1] ICON Plc, San Francisco, CA USA
[2] Tufts Med Ctr, Boston, MA 02111 USA
[3] Takeda, Cambridge, MA USA
[4] Takeda, Zurich, Switzerland
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2021年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S905
引用
收藏
页码：S427 / S427
页数：1
相关论文
共 50 条
  • [1] Clinical Remission Using the Patient-Reported Ulcerative Colitis Electronic Diary (UC e-Diary) in Adults With Moderate-to-Severe Ulcerative Colitis
    Tahir, Muna J.
    Shahraz, Saeid
    Kamble, Pravin
    Wang, Song
    Nagy, Peter
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S427 - S427
  • [2] Etrolizumab in moderate-to-severe ulcerative colitis
    Armuzzi, Alessandro
    Felice, Carla
    [J]. LANCET, 2014, 384 (9940): : 285 - 286
  • [3] Pharmacokinetics of golimumab in patients with moderate-to-severe ulcerative colitis
    Berends, S.
    Strik, A.
    van Egmond, P.
    Brandse, H.
    Mathot, R.
    D'Haens, G.
    Lowenberg, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S424 - S424
  • [4] Biologics for the treatment of moderate-to-severe ulcerative colitis in pediatric patients
    Albenberg, Lindsey G.
    Mamula, Petar
    Kelsen, Judith R.
    [J]. PEDIATRIC HEALTH MEDICINE AND THERAPEUTICS, 2012, 3 : 51 - 58
  • [5] First Oral Drug for Moderate-To-Severe Ulcerative Colitis
    Aschenbrenner, Diane S.
    [J]. AMERICAN JOURNAL OF NURSING, 2018, 118 (09) : 22 - 22
  • [6] Vedolizumab versus adalimumab for moderate-to-severe ulcerative colitis
    Tribich, Samuel
    Maurice, James
    [J]. FRONTLINE GASTROENTEROLOGY, 2020, 11 (02) : 173 - 173
  • [7] Safety evaluation of ustekinumab for moderate-to-severe ulcerative colitis
    Miyoshi, Jun
    Matsuura, Minoru
    Hisamatsu, Tadakazu
    [J]. EXPERT OPINION ON DRUG SAFETY, 2022, 21 (01) : 1 - 8
  • [8] Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
    O'Connor, Donal B.
    Lahiff, Conor
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (01): : 92 - 93
  • [9] Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
    Sands, Bruce E.
    Peyrin-Biroulet, Laurent
    Loftus, Edward V., Jr.
    Danese, Silvio
    Colombel, Jean-Frederic
    Toruner, Murat
    Jonaitis, Laimas
    Abhyankar, Brihad
    Chen, Jingjing
    Rogers, Raquel
    Lirio, Richard A.
    Bornstein, Jeffrey D.
    Schreiber, Stefan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (13): : 1215 - 1226
  • [10] CURRENT LANDSCAPE AND TREATMENTS USED IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS
    Siegel, C. A.
    Seigel, L.
    Verma, S.
    Sruti, I
    Mu, Q.
    Gupte, K.
    [J]. VALUE IN HEALTH, 2021, 24 : S99 - S99
12345